spontaneous preterm birth

Related by string. spontaneous preterm births * Spontaneous : spontaneous mutation . Spontaneous celebratory rallies . spontaneous outburst . spontaneous outbursts / Preterm : preterm labor . born preterm . preterm babies . preterm infants / births . birthing . birthed . birther : Partial Birth Abortion Ban . preventing birth defects . birth certificate immunization . birth certificate * *

Related by context. All words. (Click for frequent words.) 72 preterm delivery 70 spontaneous preterm delivery 70 singleton pregnancy 70 preterm deliveries 69 recurrent miscarriage 68 recurrent VTE 67 abnormal Pap test 66 endometrial carcinoma 66 fetal malformations 66 anovulatory infertility 65 thrombophilia 65 recurrent venous thromboembolism 65 virologic failure 65 postpartum hemorrhage 65 preterm birth 65 colorectal adenoma 65 colorectal adenomas 65 epithelial ovarian cancer 65 postoperative AF 64 placental malaria 64 recurrent preterm birth 64 chlamydial infection 64 dysglycemia 64 endometriosis ovarian cysts 64 venous thrombosis 64 chorioamnionitis 63 endometrial cancers 63 endometrial hyperplasia 63 Heavy menstrual bleeding 63 venous blood clots 63 multiple gestations 63 thromboembolic disorders 63 osteoporotic fracture 63 Cesarean deliveries 63 recurrent UTI 63 uterine rupture 63 obstetric complications 63 gestational hypertension 63 recurrent miscarriages 63 cardioembolic stroke 62 neonatal morbidity 62 SRBD 62 mammographic density 62 variceal bleeding 62 antenatal depression 62 CHD mortality 62 recurrent atrial fibrillation 62 VTEs 62 undergoing radical prostatectomy 62 neurodevelopmental outcomes 62 parous women 62 prolonged QT interval 62 bronchopulmonary dysplasia 62 thromboembolism 62 polyp recurrence 62 Postoperative complications 62 asthma exacerbation 62 CMV infection 62 ovulation induction 62 prostate cancer CaP 62 BRCA2 mutations 62 nonpregnant women 62 advanced adenoma 62 Venous thromboembolism 62 neurodevelopmental impairment 62 thrombotic events 61 pre eclamptic 61 coinfection 61 aromatase inhibitor therapy 61 subclinical hypothyroidism 61 ICD implantation 61 beta blocker therapy 61 T1DM 61 preterm births 61 vaginal hysterectomy 61 definite stent thrombosis 61 postmenopausal breast cancer 61 reinfarction 61 perinatal complications 61 thromboembolic 61 perimenopausal women 61 de ath 61 thrombotic complications 61 vertebral fracture 61 atopic disease 61 neural tube defect 61 ipsilateral stroke 61 premenopausal 61 nonvertebral fractures 61 CDI recurrence 61 GnRH agonists 61 hypoglycemic episodes 61 membrane rupture 61 renal flares 61 premenopausal breast cancer 61 abnormal uterine bleeding 61 androgen deprivation 61 NNRTI resistance 61 BRCA1 mutations 61 hereditary breast cancer 61 LNG IUS 61 intravenous bisphosphonates 61 atherothrombosis 61 venous thromboembolic disease 61 BRCA mutation carriers 61 LYSTEDA 61 abruption 61 intrapartum 61 operable breast cancer 61 recurrent DVT 61 lobular breast cancer 60 CVD mortality 60 tibolone 60 postnatally 60 cesarean deliveries 60 IgA deficiency 60 perinatal outcomes 60 fetal chromosomal 60 adenoma recurrence 60 postoperative complication 60 IUGR 60 pCR 60 HNSCC 60 uncomplicated pregnancies 60 folate supplementation 60 asymptomatic carotid stenosis 60 transfusion syndrome 60 peripartum 60 bacterial vaginosis 60 virological failure 60 triplet pregnancies 60 postoperative atrial fibrillation 60 ovulatory cycles 60 antenatal corticosteroids 60 singleton pregnancies 60 R0 resection 60 LV dysfunction 60 dysfunctional voiding 60 lobular cancer 60 thromboembolic disease 60 PROCHIEVE 8 60 primary ovarian insufficiency 60 confidence interval #.#-#.# 60 genital herpes infections 60 spontaneous preterm births 60 Caesarean deliveries 60 polycystic ovary syndrome 60 VT VF 60 polycystic ovary syndrome PCOS 60 postoperative mortality 60 ovarian hyperstimulation syndrome OHSS 60 aneurysmal subarachnoid hemorrhage 60 abnormal Pap smear 60 precancerous cervical lesions 60 advanced neoplasia 60 anal incontinence 60 thyroid hormone levels 60 β blockers 60 nonmelanoma skin cancers 60 diabetes mellitus DM 60 tamoxifen therapy 60 thromboembolic events 60 neurodevelopmental outcome 60 oocytes retrieved 60 postpartum haemorrhage 60 abnormal Pap smears 60 IPAH 60 Adjuvant chemotherapy 60 pre menopausal 60 adnexal mass 60 antithrombotic therapy 60 invasive aspergillosis 60 delaying childbirth 60 varicella infection 59 cerebral vasospasm 59 Sexual dysfunction 59 Postnatal depression 59 virological response 59 tumor histology 59 irregular menstrual cycles 59 venous thromboembolic events 59 secondary amenorrhea 59 adenomatous polyps 59 clomiphene citrate 59 oophorectomy 59 paroxetine Paxil 59 Pulmonary embolism 59 rFVIIa 59 ovulatory 59 serum estradiol 59 cerebral microbleeds 59 DVT PE 59 perioperative mortality 59 carotid IMT 59 congenital CMV 59 leiomyomas 59 contrast induced nephropathy 59 fragility fracture 59 ductal breast cancer 59 sodium valproate 59 NATRECOR ® 59 severe asthma exacerbations 59 BRCA mutation 59 dysmenorrhea 59 glycated hemoglobin levels 59 plasma folate 59 Erythropoietic therapies may 59 cerebral infarction 59 intraventricular hemorrhage 59 TEAEs 59 upper gastrointestinal bleeding 59 colorectal neoplasia 59 potentially modifiable 59 endometrial thickness 59 Preterm delivery 59 syncopal 59 recurrent wheezing 59 Arch Intern Med 59 fibroids endometriosis 59 Prostatitis 59 palivizumab 59 postoperative delirium 59 perinatal depression 59 sulphonylureas 59 advanced adenomas 59 aneurysm rupture 59 biochemical relapse 59 venous thromboembolism 59 IM progesterone 59 severe neutropenia 59 breast cancer recurrences 59 cerebrovascular accidents 59 tubal pregnancies 59 dysmenorrhoea 59 testosterone supplementation 59 neurocognitive impairment 59 % CI #.#-#.# [008] 59 nulliparous women 59 postoperative morbidity 59 elevated LDL cholesterol 59 ALT flares 59 carotid plaques 58 HGPIN 58 ovulations 58 HER2 overexpression 58 CC genotype 58 alpha hydroxyprogesterone caproate 58 bilateral oophorectomy 58 cervical lesions 58 abnormal mammograms 58 LQTS 58 born preterm 58 placental abruption 58 precancerous cervical 58 relapsed MM 58 thrombocytopenic 58 antidiabetic medication 58 overt hepatic encephalopathy HE 58 salmeterol HFA MDI 58 neurocognitive deficits 58 PSADT 58 elevated CRP 58 luteal phase 58 ABCB1 58 latent tuberculosis infection 58 neurologic complications 58 atypical hyperplasia 58 molar pregnancy 58 severe rotavirus gastroenteritis 58 hemorrhagic complications 58 antiandrogen 58 haemorrhagic stroke 58 myocardial infarctions MIs 58 KIF6 carriers 58 BRCA1 mutation carriers 58 premenstrual syndrome PMS 58 intracerebral hemorrhage 58 nonmelanoma skin cancer 58 androgen suppression 58 atherogenic dyslipidemia 58 amenorrhoea 58 macrovascular events 58 BRCA carriers 58 rFSH 58 preterm 58 symptomatic VTE 58 pathologic fractures 58 urolithiasis 58 onset sepsis 58 relapsed ALL 58 TT genotype 58 pharmacologic treatments 58 modifiable risk 58 HIV seroconversion 58 testicular germ cell 58 corticosteroid dose 58 estrogen progestin therapy 58 conjugated equine estrogen 58 folate intake 58 herpes zoster shingles 58 habitual snoring 58 HbF 58 SHBG levels 58 orofacial clefts 58 Myocardial infarction 58 onset diabetes mellitus 58 pathologic fracture 58 invasive meningococcal disease 58 perinatal mortality 58 candidemia 58 normotensive 58 abnormal lipid 58 bolus dose 58 patients undergoing CABG 58 C. trachomatis 58 nonadherence 58 sonographic diagnosis 58 menstrual bleeding 58 carotid stenosis 58 venous thromboembolic 58 myocardial infarction MI 58 CMV disease 58 HIV seronegative 58 adjuvant radiotherapy 58 recurrent genital herpes 58 cranial irradiation 58 varicocele 58 ruptured aneurysms 58 morphometric vertebral fractures 58 corifollitropin alfa 58 ELBW infants 58 BRCA mutations 58 diagnosed prenatally 58 pregnancies 58 nadroparin 58 angiographic restenosis 58 clinically insignificant 58 rebleeding 58 bacterial vaginosis BV 58 serum phosphate 58 anovulation 58 Cesarean delivery 58 premature menopause 58 amenorrhea 58 depot medroxyprogesterone acetate 58 proximal DVT 58 external genital lesions 58 undergoing bariatric surgery 58 inhaled budesonide 58 severe hypoglycemic 57 arterial thromboembolic events 57 fetal abnormalities 57 bronchopulmonary dysplasia BPD 57 tumor recurrence 57 monoclonal gammopathy 57 abnormal Pap 57 ventricular tachyarrhythmia 57 intestinal polyps 57 Recurrences 57 testicular tumors 57 thromboembolic complications 57 hyperphenylalaninemia HPA due 57 perioperative morbidity 57 pelvic inflammatory disease 57 incontinence episodes 57 CHDs 57 bowel resection 57 ximelagatran 57 ovarian hyperstimulation 57 obstetric interventions 57 platelet reactivity 57 MYCN amplification 57 VLBW 57 preterm labor 57 thyrotropin levels 57 irregular menstrual periods 57 DHA supplementation 57 myelomeningocele 57 cardiovascular mortality 57 gallstone disease 57 #.#ng/ml 57 MGUS 57 colorectal neoplasms 57 adverse perinatal 57 Complication rates 57 postmenopausal 57 ischemic strokes 57 PPCM 57 VUR 57 asymptomatic hypothyroidism 57 Chlamydia infection 57 hyperbilirubinemia 57 node metastases 57 recurrent stroke 57 recurrent glioblastoma multiforme 57 perioperative complications 57 subfertility 57 cervical intraepithelial neoplasia 57 postmenopausal osteoporotic women 57 chromosomal alterations 57 pelvic lymphadenectomy 57 Ovary removal 57 gynecologic malignancy 57 atypia 57 vasomotor symptoms 57 lipid abnormalities 57 endometrial cancer 57 SSRI antidepressant 57 cervicitis 57 CIN3 57 ertapenem 57 heavy menstrual bleeding 57 serum aminotransferase levels 57 atypical ductal hyperplasia 57 cerebrovascular events 57 BRCA2 mutation carriers 57 STRIDE PD 57 polytherapy 57 acute leukemias 57 vulvovaginal candidiasis 57 EBRT 57 elevated triglyceride levels 57 weeks gestation 57 Hashimoto thyroiditis 57 perinatal transmission 57 serum calcium levels 57 HER2 expression 57 folic acid supplementation 57 vaginal deliveries 57 nonvertebral fracture 57 postoperative pulmonary 57 germline mutations 57 gestational diabetes mellitus 57 renal scarring 57 seropositivity 57 teratogenic 57 uterine bleeding 57 RSV infections 57 T2DM 57 NATRECOR R 57 shorter telomere length 57 nocturnal hypoglycaemia 57 persistent pulmonary hypertension 57 PRADAXA 57 uterine tumors 57 superinfection 57 postmenopausal hormone replacement 57 COPD exacerbations 57 CHD CVD 57 dopaminergic therapy 57 basal cell nevus syndrome 57 retrospective cohort 57 invasive ductal breast cancer 57 hyperemesis 57 serum lipid levels 57 neural tube birth defects 57 Trichomonas vaginalis 57 PREMPRO 57 hypertensive disorders 57 genital ulcers 57 MYH9 gene 57 preeclampsia 57 elective caesarean section 57 myocardial infarctions 57 invasive cervical cancer 57 precocious puberty 57 Oral contraceptives 57 post thrombotic syndrome 57 PRADAXA #mg 57 euthyroid 57 allogeneic HSCT 57 statin medications 57 gastrointestinal bleeds 57 afib 57 Febrile neutropenia 57 postoperative complications 57 hepatectomy 57 recurrent UTIs 57 Inhibin B 57 thrombo embolic 57 cerebral infarctions 57 elective cesarean delivery 57 AVODART 57 AMOR IPAT 57 citalopram Celexa 57 flutamide 57 Klinefelter syndrome 57 atrophic gastritis 57 Low birthweight 57 cryptorchidism 57 lipid lowering therapy 57 subclinical hyperthyroidism 57 HIV HCV coinfected 57 thromboembolisms 57 tamoxifen Nolvadex ® 57 PAOD 57 adenotonsillectomy 57 antiplatelet medications 57 anovulatory 57 Rh incompatibility 57 HBeAg seroconversion 57 subtrochanteric 57 antiretroviral naive 56 cranial radiation 56 vaginal atrophy 56 placenta praevia 56 hematopoietic cancers 56 intracranial hemorrhage ICH 56 grade cervical intraepithelial 56 elevated depressive symptoms 56 systemic toxicity 56 serum IGF 56 ATACAND 56 microvascular disease 56 invasive candidiasis 56 unexplained stillbirth 56 Gestational diabetes 56 postoperative infections 56 estrogen hormone therapy 56 de aths 56 ADPKD 56 contralateral breast cancer 56 Estrogens 56 aged ≥ 56 osteoporotic fractures 56 ductal carcinomas 56 nonfatal MI 56 genotypic resistance 56 peripartum cardiomyopathy 56 ticlopidine 56 gonococcal infection 56 intracranial stenosis 56 PPHN 56 Tardive dyskinesia 56 suicide ideation 56 atypical fractures 56 serum uric acid 56 APTIVUS r 56 Myelodysplastic syndromes MDS 56 puerperal psychosis 56 HBeAg 56 opioid dependent 56 gestational diabetes 56 HeFH 56 GnRH agonist 56 proliferative retinopathy 56 mIU ml 56 GBA mutations 56 ovarian hyperstimulation syndrome 56 poor metabolizers 56 CMV infections 56 TTTS 56 histological subtype 56 atherothrombotic events 56 apolipoprotein E4 56 asthma exacerbations 56 postmenopausal hormones 56 VTE 56 HMG CoA reductase inhibitors 56 HBV infection 56 HBV infections 56 Genetic variants 56 inhospital 56 CRBSI 56 invasive carcinoma 56 paroxysmal AF 56 carotid atherosclerosis 56 cervical carcinoma 56 MetS 56 caesarean delivery 56 hypoglycaemic episodes 56 congenital anomalies 56 VLBW infants 56 valproate 56 ductal cancer 56 invasive breast cancer 56 QTc interval 56 PGD PGS 56 comorbid conditions 56 oligohydramnios 56 birthweight 56 nulliparous 56 HNPCC 56 A1c levels 56 extrapyramidal symptoms 56 SLNB 56 placenta accreta 56 recurrent ischemic stroke 56 antihypertensive therapy 56 ectopic pregnancies 56 underwent coronary angiography 56 depressive relapse 56 DHEA supplementation 56 G6PD deficiency 56 cervical vaginal 56 fluvastatin 56 elevated bilirubin 56 postexposure prophylaxis 56 abnormal vaginal bleeding 56 pelvic malignancies 56 coronary revascularization 56 PIGF 56 post surgical adhesions 56 autoantibody levels 56 psychiatric comorbidities 56 preeclamptic 56 dyslipidaemia 56 lipid lowering drugs 56 atherothrombotic 56 immunosuppressant therapy 56 abacavir Ziagen 56 comorbid disorders 56 Pneumocystis carinii pneumonia 56 HER2 amplified 56 serum urate levels 56 colorectal cancer incidence 56 liver transplant recipients 56 prospective longitudinal 56 angina myocardial infarction 56 prostate carcinogenesis 56 prepregnancy BMI 56 % CI #.#-#.# [003] 56 amniotic fluid embolism 56 renoprotective 56 CYP#D# genotype 56 HPA axis suppression 56 antibiotic prophylaxis 56 treat dysmenorrhea 56 intensive statin therapy 56 binary restenosis 56 mycophenolate mofetil MMF 56 hypogonadal men 56 antiretroviral naïve 56 Polycystic ovary syndrome PCOS 56 estrogen therapy 56 gestational glucose intolerance 56 thyroid dysfunction 56 pg ml 56 intra uterine 56 nocturnal hypoglycemia 56 luteal 56 symptomatic intracranial hemorrhage 56 complete cytogenetic response 56 seroconversion 56 BRCA2 gene mutation 56 biochemical recurrence 56 severe hypoglycaemia 56 letrozole Femara 56 thiazide diuretic 56 GnRH antagonist 56 antiarrhythmic medications 56 preterm newborns 56 vaccinees 56 androgen deficiency 56 Hydroxyurea 56 utero exposure 56 transaminase levels 56 severe hypersensitivity reactions 56 HbA 1c levels 56 breast cancer recurrence 56 Endometrial cancer 56 BCG vaccinated 56 corrected QT interval 56 aromatase inhibitors AIs 56 PONV 56 neutropenic 56 cyclic HMB 56 stratifying patients 56 adenoma 56 virologic response 56 coagulation abnormalities 56 renal toxicity 56 Subarachnoid hemorrhage 56 HAART initiation 56 colorectal polyps 56 lignan intake 56 abnormal Pap tests 56 epithelial ovarian 56 anagrelide 56 oocyte retrieval 56 infertility ectopic pregnancy 56 thromboprophylaxis 56 EpCAM expression 56 postmenopausal estrogen 56 severe exacerbations 56 ASCUS 56 serum creatinine levels 56 cardiovascular morbidity 56 ischemic cardiovascular 56 mycophenolate mofetil 56 hypothalamic amenorrhea 56 salpingo oophorectomy 56 Vitamin D supplementation 56 medroxyprogesterone acetate 56 bilirubin levels 56 histologic subtype 56 urethritis 56 hormone therapy estrogen 56 induce ovulation 56 postmenopausal hormone 56 sideeffects 56 postmenopausal hormone therapy 56 Prehypertension 56 gestational diabetes mellitus GDM 56 intima media thickness 56 nondepressed 56 pulmonary resection 55 HBeAg negative 55 systolic BP 55 severe hypoglycemia 55 aneuploidy screening 55 colon adenomas 55 BRCA gene mutation 55 corticosteroid therapy 55 coinfected patients 55 albumin excretion 55 periprocedural MI 55 RhD negative 55 intracerebral 55 prenatally diagnosed 55 del 5q MDS 55 thiopurine 55 cardiovascular hospitalizations 55 terbutaline 55 polycystic ovarian syndrome PCOS 55 genital ulcer disease 55 EXJADE 55 ischemic complications 55 metabolic abnormalities 55 Calcium supplementation 55 arterial calcification 55 etiologic 55 serogroup C 55 elective caesarean sections 55 abnormal mammogram 55 congenital malformations 55 cesarean delivery 55 cardio metabolic 55 hormone therapy HT 55 Dietary Modification Trial 55 MS relapses 55 locoregional recurrence 55 CIN2 + 55 Influenza vaccination 55 serum parathyroid hormone 55 adjuvant tamoxifen 55 subclinical atherosclerosis 55 Unintended pregnancies 55 undergone radical prostatectomy 55 Hip fracture 55 familial hypercholesterolemia 55 Ophena TM 55 lichen planus 55 haematological toxicity 55 recurrent myocardial infarction 55 acute myocardial infarctions 55 nonfatal stroke 55 APOE e4 55 ibandronate 55 MMSE score 55 hereditary antithrombin deficient 55 post partum haemorrhage 55 primary hyperparathyroidism 55 cardiac repolarization 55 chlamydia infections 55 noncardiac surgery 55 keloid scarring 55 hemodialysis patients 55 ribavirin therapy 55 faulty BRCA genes 55 Kaplan Meier analysis 55 untreated sleep apnea 55 estrogen receptor negative 55 Premenopausal women 55 torsade de pointes 55 chlamydial infections 55 antiplatelet drugs 55 Calcium intake 55 hydroxyvitamin D levels 55 noncardiac 55 prolactin levels 55 COPEGUS therapy 55 abnormal cytology 55 Wactawski Wende 55 postoperative radiotherapy 55 eptifibatide 55 selenium supplementation 55 venous thromboembolism VTE 55 EFFEXOR XR 55 type 1diabetes 55 pyelonephritis 55 serum concentrations 55 microalbuminuria 55 QALE 55 irregular ovulation 55 menarche 55 invasive ductal 55 impair fertility 55 AAT deficiency 55 intraoperative complications 55 cesareans 55 preterm neonates 55 antioxidant supplementation 55 octreotide LAR 55 uterine cancers 55 cosmetic breast implants 55 low birthweight 55 dose ionizing radiation 55 axillary dissection 55 NOLVADEX 55 prescribed statins 55 macrosomia 55 LTBI 55 cervical dysplasia 55 prenatal exposures 55 distal colon cancer 55 lipid elevations 55 HbA1C levels 55 MTHFR 55 dietary calcium intake 55 singleton babies 55 CLINICAL STUDIES 55 vulvovaginal atrophy 55 noncardiovascular mortality 55 irregular menses 55 IFN beta 55 sustained ventricular tachycardia 55 preterm infant 55 cryptogenic stroke 55 anal cancers 55 periprocedural 55 ruptured ectopic 55 hip BMD 55 urinary symptoms 55 intracerebral hemorrhages 55 colorectal bowel 55 vaginal progesterone gel 55 Natazia 55 pharmacologic intervention 55 Premature menopause 55 Thyroid disorders 55 atypical femur fractures 55 warfarin therapy 55 neutrophil counts 55 potassium sparing diuretics 55 febrile seizure 55 follicular phase 55 HIV uninfected 55 lumbar spine BMD 55 curative resection 55 virologic breakthrough 55 gestational age 55 renal dysfunction 55 Hypotension 55 HBsAg 55 Treatment emergent adverse 55 thromboses 55 atrial arrhythmias 55 fatal IHD 55 valacyclovir 55 BENICAR HCT 55 metastatic malignant 55 malignant neoplasm 55 antidiabetic medications 55 preoperative PSA 55 oral contraceptive pills 55 Hormonal therapy 55 % CI #.#-#.# [006] 55 elevated transaminases 55 Stent thrombosis 55 NMIBC 55 tachyarrhythmias 55 HER2 positive cancers 55 atherothrombotic disease 55 ovarian carcinoma 55 cisplatin chemotherapy 55 progesterone receptor negative 55 hemolytic disease 55 orchiectomy 55 IVF ICSI 55 acromegalic patients 55 postmenopause 55 Gestational age 55 Genetic predisposition 55 hepatitis C genotype 55 breast carcinoma 55 neurologic sequelae 55 progestin therapy 55 axillary node 55 bicuspid aortic valves 55 fragility fractures 55 symptomatic hypoglycemia 55 umbilical artery 55 thromboembolic diseases 55 conjugated equine estrogens 55 methotrexate therapy 55 CRESTOR #mg 55 neurocognitive outcomes 55 adjuvant hormonal therapy 55 multivariate Cox 55 eculizumab therapy 55 pyridostigmine 55 rs# [004] 55 colorectal cancer CRC 55 Hilakivi Clarke 55 prognostic indicators 55 poorer prognosis 55 APOL1 55 arterial thrombotic 55 uncontrolled asthma 55 reproductive tract infections 55 polyhydramnios 55 symptomatic intracranial 55 BRCA2 mutation 55 penetrance 55 pre eclampsia 55 Ectopic pregnancy 55 Uterine cancer 55 anthracycline taxane 55 proband 55 clodronate 55 Tranexamic acid 55 GISTs 55 isotretinoin 55 folic acid intake 55 hemodilution 55 coinfected 55 uterine scar 55 noncarriers 55 hepatotoxicity 55 CrCl 55 non valvular atrial 55 gefitinib Iressa 55 antimicrobial prophylaxis 55 androgen excess 55 antiarrhythmic drugs 55 ELBW 55 ORTHO TRI CYCLEN LO 55 H. pylori eradication 55 plasma homocysteine levels 55 gastrointestinal malignancies 55 diabetic kidney 55 GH deficiency 55 acute coronary 55 hematologic abnormalities 55 progestagen 55 prophylactic oophorectomy 55 recurrent tonsillitis 55 overt nephropathy 55 T1c 55 TCF#L# gene 55 antiphospholipid syndrome 55 calcium supplementation 55 quadrivalent vaccine 55 Preterm infants 55 underwent resection 55 postsurgical complications 55 comorbid depression 55 posttransplant 55 hMG 55 PHPT 55 venlafaxine Effexor 55 ICD shocks 55 clinically localized prostate 55 Gynecologists recommends 55 bisphosphonate therapy 55 microbleeds 55 SUVmax 55 REYATAZ r arm 55 baseline HbA1c 54 BRCA testing 54 autoimmune thyroiditis 54 prepubertal 54 #beta HSD1 54 fibrinolysis 54 deep venous thromboses 54 recurrent ischemic 54 undergoing coronary angiography 54 initiating antiretroviral therapy 54 hypovitaminosis D 54 PROCHIEVE 54 leukemia ALL 54 knee osteoarthritis OA 54 antiplatelet therapy 54 elevated hsCRP 54 Antiretroviral therapy 54 gonadotropins 54 menstrual abnormalities 54 prothrombotic 54 obese postmenopausal 54 oral contraceptive pill 54 overt hypothyroidism 54 chronic rhinosinusitis 54 longitudinal cohort study 54 antibody titer 54 smoldering myeloma 54 dosing cohort 54 hematologic toxicity 54 precancerous condition

Back to home page